Literature DB >> 8892593

Growth kinetics of colorectal adenoma-carcinoma sequence: an immunohistochemical study of proliferating cell nuclear antigen expression.

H B Yang1, P I Hsu, S H Chan, J C Lee, J S Shin, N H Chow.   

Abstract

Tumorigenesis is a multistep process that begins with the abrogation of normal controls of cell proliferation. The authors examined the in vitro growth kinetics and compartment shift through the adenoma-carcinoma sequence of the human colon by determining the labelling indexes of proliferating cell nuclear antigen (PCNA) in normal mucosae (n = 10), adenomas (n = 88), and carcinomas (n = 20). Carcinoma cells had a significantly higher PCNA index than adenomas or control specimens (P = .0001). There also was a difference in the PCNA index between the histological subtypes of adenomas (P = .03), whereas no significant difference was observed for dysplastic grade, tumor size, or location (P > .1). Tubular and tubulovillous adenomas, adenomas with mild dysplasia, small (< 10 mm) adenomas, and proximally located adenomas revealed shift of cell proliferation toward the middle portion of the colonic glands. The PCNA in the villous, moderate or severe dysplastic, larger or distally located adenomas appeared to be diffuse (P = .04, 0.02, 0.07, and 0.06, respectively). In addition, the transitional mucosa neighboring carcinoma showed an elevation of the mean PCNA index together with an upward shift of cell proliferation compared with the controls (P = .03). These results suggest a stepwise increment of proliferating activity with compartment shift of the proliferating zone through the adenoma-carcinoma sequence. The information essentially supports contemporary understanding of the carcinogenic processes in the human colon.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8892593     DOI: 10.1016/s0046-8177(96)90286-5

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  9 in total

1.  Oncocytic adenocarcinoma of the rectum arising on a villous adenoma with oncocytic features.

Authors:  Simonetta Piana; Silvia Asioli; Moira Foroni
Journal:  Virchows Arch       Date:  2006-02-01       Impact factor: 4.064

2.  Correlation of bcl-2 oncoprotein immunohistochemical expression with proliferation index and histopathologic parameters in colorectal neoplasia.

Authors:  H A Saleh; H Jackson; G Khatib; M Banerjee
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

3.  Improved innate immune responses by Frondanol A5, a sea cucumber extract, prevent intestinal tumorigenesis.

Authors:  Naveena B Janakiram; Altaf Mohammed; Taylor Bryant; Stan Lightfoot; Peter D Collin; Vernon E Steele; Chinthalapally V Rao
Journal:  Cancer Prev Res (Phila)       Date:  2015-02-05

4.  Identification of HLA-A*0201-restricted cytotoxic T lymphocyte epitope from proliferating cell nuclear antigen.

Authors:  Wei Xu; Hui-Zhong Li; Jun-Jie Liu; Zhen Guo; Bao-Fu Zhang; Fei-Fei Chen; Dong-Sheng Pei; Jun-Nian Zheng
Journal:  Tumour Biol       Date:  2010-08-16

5.  Expression of fibroblast growth factor-1 and fibroblast growth factor-2 in normal liver and hepatocellular carcinoma.

Authors:  N H Chow; K S Cheng; P W Lin; S H Chan; W C Su; Y N Sun; X Z Lin
Journal:  Dig Dis Sci       Date:  1998-10       Impact factor: 3.199

6.  Immunohistochemical expression of PCNA and CD34 in colorectal adenomas and carcinomas using specified automated cellular image analysis system: a clinicopathologic study.

Authors:  Ban J Qasim; Hussam H Ali; Alaa G Hussein
Journal:  Saudi J Gastroenterol       Date:  2012 Jul-Aug       Impact factor: 2.485

7.  MiR-34b inhibits the proliferation and promotes apoptosis in colon cancer cells by targeting Wnt/β-catenin signaling pathway.

Authors:  Kailun Ye; Chunhua Xu; Tongguan Hui
Journal:  Biosci Rep       Date:  2019-10-30       Impact factor: 3.840

8.  Cell-cycle and apoptosis related and proteomics-based signaling pathways of human hepatoma Huh-7 cells treated by three currently used multi-RTK inhibitors.

Authors:  Xuejiao Ren; Qingning Zhang; Wenyan Guo; Lan Wang; Tao Wu; Wei Zhang; Ming Liu; Dezhi Kong
Journal:  Front Pharmacol       Date:  2022-08-22       Impact factor: 5.988

9.  Circ_cse1l Inhibits Colorectal Cancer Proliferation by Binding to eIF4A3.

Authors:  Bin Xu; Ning Yang; Yabin Liu; Peng Kong; Mei Han; Binghui Li
Journal:  Med Sci Monit       Date:  2020-08-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.